MLAB · Mesa Laboratories Inc /Co/ · Documents
$125.90
+2.60 (+2.10%)
At close · Oct 20
View the 10-K filed Jun 3, 2026
Return incl. dividend (before tax)
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$690.00M
Shares
5.60M
Volume · Oct 20
77.23K
Avg daily vol (3M)
133.1K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-K | — | 2023-05-30 | 2023-03-31 | |
| 8-K | — | 2023-05-25 | — | |
| 8-K | — | 2023-05-08 | 2023-05-03 | |
| 8-K | — | 2023-03-13 | 2023-03-10 | |
| 8-K | — | 2023-02-06 | — | |
| 10-Q | — | 2023-02-06 | 2022-12-31 | |
| 8-K/A | — | 2023-01-04 | 2022-08-26 | |
| 8-K | — | 2022-11-21 | 2022-11-16 | |
| 8-K | — | 2022-11-04 | 2022-11-03 | |
| 8-K/A | — | 2022-11-04 | 2022-06-23 | |
| 8-K | — | 2022-11-03 | — | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-08-26 | — | |
| DEFA14A | — | 2022-08-23 | — | |
| DEFA14A | — | 2022-08-22 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | — | |
| DEF 14A | — | 2022-07-14 | 2022-08-26 | |
| 8-K | — | 2022-06-27 | 2022-06-23 | |
| 8-K | — | 2022-05-31 | — | |
| 10-K | — | 2022-05-31 | 2022-03-31 | |
| 8-K | — | 2022-04-11 | 2022-04-08 | |
| 8-K | — | 2022-04-05 | — | |
| S-3ASR | — | 2022-04-05 | — | |
| 8-K | — | 2022-03-30 | — | |
| 8-K | — | 2022-02-03 | — | |
| 10-Q | — | 2022-02-03 | 2021-12-31 | |
| 8-K | — | 2021-12-23 | — | |
| 8-K/A | — | 2021-12-22 | 2021-10-18 | |
| 8-K | — | 2021-11-04 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 8-K | — | 2021-10-29 | 2021-10-28 | |
| 8-K | — | 2021-10-21 | 2021-10-18 | |
| 8-K | — | 2021-09-29 | 2021-09-24 | |
| 8-K | — | 2021-09-14 | 2021-09-13 | |
| 8-K | — | 2021-09-03 | 2021-08-30 | |
| 8-K | — | 2021-08-27 | — | |
| 8-K | — | 2021-08-05 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| DEF 14A | — | 2021-07-16 | 2021-08-27 | |
| 10-K | — | 2021-06-01 | 2021-03-31 | |
| 8-K | — | 2021-06-01 | — | |
| 8-K | — | 2021-03-08 | 2021-03-05 | |
| 10-Q | — | 2021-02-03 | 2020-12-31 | |
| 8-K | — | 2021-02-03 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-10-01 | 2020-09-28 | |
| 8-K | — | 2020-08-28 | — | |
| DEFA14A | — | 2020-08-20 | — |
Showing 51–100 of 114 filings
Key facts
CIK
724004
CUSIP
59064R109
13F (30d)
16 filings
16 filers
Visit website
Investor relations